GLP-1RAs, such as lixisenatide, not only rely on -cell function and glucagon suppression, but also assist to lower glucose by other (insulin-independent) mechanisms such as delayed gastric emptying, underlying the clinical utility of GLP-1RAs as adjuvant therapy to basal insulin in longstanding T2DM [14]
Like GLP-1 itself, and like an earlier drug, liraglutide, that was approved in 2010, it suppresses the release of glucagon a hormone secreted by the pancreas to raise blood sugar levels
Rath D, Chatterjee M, Borst O, Mller K, Stellos K, Mack AF, Bongartz A, Bigalke B, Langer H, Schwab M, Gawaz M, Geisler T
There is no clinical evidence supporting any interval other than once weekly
A mid-morning snack of raw almonds and hazelnuts can help sustain energy levels, improve focus, and prevent mid-day fatigue